Loading
SB
Sophiris Bio Inc. Stock: price and insider trades · Canada
No insider purchase over the last 90 days. The latest, by WOODS RANDALL E, was filed 20 Sept 2018.
Sophiris Bio Inc.: what insiders have been doing
Every trade that managers of Sophiris Bio Inc. disclose to SEDI is tracked on this page. The past year has been quiet: not a single insider filing for Sophiris Bio Inc. The previous disclosure was published on 20 September 2018.
The full history, which starts in 2016, counts 2 purchases against no sales.
Source: insider filings from SEDI. Past trades are no guide to future returns.
Insider Decl.
12
Thresholds
n/a
Buy Volume
€39,990
2 ops. · all time
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
Last declaration on 20 September 2018
Declarations12 total
10,000 shares@ US$2.63100.0% of flowCommon StockSEC:0001209191-18-051751:0
Canonical exit: 18 Dec 2018 (T+90)
10,000 shares@ CA$2.6339100.0% of flowCommon SharesTSXSEDI:3238775
Canonical exit: 18 Dec 2018 (T+90)
2,882 sharesCommon SharesTSXSEDI:2956527
1,318 shares0Common SharesSEC:0001209191-17-008918:0
2,000 sharesCommon SharesTSXSEDI:2911120
9,805,119 sharesCommon SharesTSXSEDI:2911142
132,760 sharesCommon SharesTSXSEDI:2911131
1,000,000 sharesCommon SharesTSXSEDI:2911126
49,999 sharesCommon SharesTSXSEDI:2911134
38 sharesCommon SharesTSXSEDI:2907368
488,905 sharesCommon SharesTSXSEDI:2907385
38 shares0Common SharesSEC:0001209191-16-147520:0
12 of 12 declarations
About Sophiris Bio Inc.
Sophiris Bio Inc. is a biopharmaceutical company focused on developing treatments for urological diseases. It is listed on the Toronto Stock Exchange (XTSE).
